FR

Frederic Revah

AS Aventis Pharma S.A.: 7 patents #53 of 591Top 9%
RS Rhone-Poulenc Rorer S.A.: 1 patents #153 of 323Top 50%
SA Sanofi-Aventis: 1 patents #285 of 563Top 55%
Overall (All Time): #512,265 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
9284252 Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders Max Herzberg 2016-03-15
8431119 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases Jacques Mallet, Jean-Marie Stutzmann 2013-04-30
7273854 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative disorders Jacques Mallet, Jean-Marie Stutzmann 2007-09-25
7241591 Adenovirus comprising a gene coding for glutathione peroxidase Martine Barkats, Jacques Mallet 2007-07-10
6723315 Method for treating amyotrophic lateral sclerosis Jacques Mallet, Philippe Kennel, Axel Kahn, Georg Haase 2004-04-20
6685934 Recombinant adenoviruses coding for basic fibroblast growth factors (BFGF) Jacques Mallet, Michel Perricaudet, Emmanuelle Vigne, Marc Abitbol, Paul Roustan 2004-02-03
6632427 Adenoviral-vector-mediated gene transfer into medullary motor neurons Françoise Finiels, Minerva Gimenez-Ribotta, Jacques Mallet, Alain Privat 2003-10-14
6552003 Muscle reinnervation and motor axon sprouting by administering DNA sequences encoding NT-3 and CNTF Françoise Finiels, Minerva Gimenez-Ribotta, Jacques Mallet, Alain Privat 2003-04-22
6245330 Recombinant adenoviruses coding for glial-derived neurotrophic factor (GDNF) Philippe Horellou, Jacques Mallet, Michel Perricaudet, Emmanuelle Vigne 2001-06-12
6140112 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases Jacques Mallet, Jean-Jacques Robert 2000-10-31